LEXINGTON, Massachusetts, May 25, 2017 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that FlemmingOrnskov, MD, Chief Executive Officer, will participate at the Jefferies Healthcare Conference in New York City, NY on Thursday, June 8, 2017 at 3:00 PM EDT (
A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://investors.shire.com/. Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.
NOTES TO EDITORS
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
For further information please contact:
Investor Relations Ian Karp firstname.lastname@example.org +1-781-482-9018
Robert Coates email@example.com +44-1256-894874
SOURCE Shire plc
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All